Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy

Overview

Vitamin D is available in two forms, vitamin D2 and vitamin D3. It has previously been assumed that these two forms maintain blood vitamin D equally. However, this may not be the case. This study will evaluate whether D2 and D3 produce equal elevation of blood vitamin D. Additionally, it will evaluate whether once per month vitamin D dosing is as effective in maintaining blood vitamin D levels as daily dosing.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Investigator)
  • Study Primary Completion Date: November 2008

Interventions

  • Dietary Supplement: Cholecalciferol (vitamin D3)
    • 50,000 IU once monthly for 12 months
  • Dietary Supplement: Ergocalciferol (vitamin D2)
    • oral capsule 50,000 IU once monthly for 12 months
  • Dietary Supplement: Ergocalciferol (vitamin D2)
    • oral capsule 1600 IU once daily for 12 months
  • Dietary Supplement: Cholecalciferol (vitamin D3)
    • oral capsule 1600 IU once daily for 12 months
  • Dietary Supplement: Placebo
    • oral placebo capsule once daily for 12 months

Arms, Groups and Cohorts

  • Experimental: 1
  • Experimental: 2
  • Experimental: 3
  • Experimental: 4

Clinical Trial Outcome Measures

Primary Measures

  • The primary outcome measure is change in 25OHD with various D2 and D3 dosing regimens.
    • Time Frame: 12 months

Secondary Measures

  • Determine whether once monthly vitamin D2 or D3 dosing is as effective as daily dosing in attainment, and subsequent maintenance, of 25OHD status
    • Time Frame: 12 months
  • Delineate the effect of these vitamin D regimens on other parameters of skeletal relevance
    • Time Frame: 12 months

Participating in This Clinical Trial

Inclusion Criteria

1. Community dwelling men and women age ≥ 65 years. 2. Able and willing to sign informed consent. 3. Serum 25OHD concentration ≥ 10 and less than 60 ng/ml by HPLC. 4. Willing to avoid use of cod-liver oil and non-study vitamin D supplementation; standard multiple vitamins containing ≤ 400 IU used no more than once daily will be allowed Exclusion Criteria:

1. Current hypercalcemia (serum calcium > 10.5 mg/dl) or untreated primary hyperparathyroidism. 2. History of nephrolithiasis. 3. Screening 25OHD concentration ≥ 60 ng/ml. 4. Baseline 24-hour urine calcium > 250 mg if female, > 300 mg if male. 5. Known risk factors for hypercalcemia, e.g., malignancy, tuberculosis, sarcoidosis, Paget's disease 6. History of any form of cancer within the past five years with the exception of adequately treated squamous cell or basal cell skin cancer. 7. Renal failure defined as a calculated creatinine clearance (Cockroft-Gault method) ≤ 25 ml/minute 8. Severe end-organ disease, e.g., cardiovascular, hepatic, hematologic, pulmonary, etc., which may limit ability to complete the study 9. Known malabsorption syndromes, e.g., celiac disease, radiation enteritis, active inflammatory bowel disease, etc. 10. Use of medications known to alter bone turnover including bisphosphonates, estrogen, selective estrogen receptor modulators, PTH, testosterone or calcitonin 11. Vitamin D intake greater than 5,000 IU daily 12. Treatment with any active metabolites of vitamin D within six months of screening 13. Treatment with any drug which may interfere with vitamin D metabolism, e.g., phenobarbital, phenytoin.

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Wisconsin, Madison
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Neil Binkley, MD, Principal Investigator, University of Wisconsin – Institute on Aging

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.